Dialectic Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Dialectic Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,000	Closed	-$531K	–	117
2016 Q3	$531K	Buy	+4,000	New	+$382K	0.33%	64
2016 Q2	–	Sell	-3,500	Closed	-$252K	–	129
2016 Q1	$252K	Buy	+3,500	New	+$192K	0.12%	91

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dialectic Capital Management's GWPH Position: Q4 2016 in Review

Dialectic Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2016, closing a stake of 4,000 shares — an estimated $531K sold.

Dialectic Capital Management first reported a position in GWPH in Q1 2016 and held it in 2 quarters. The position peaked at $531K in Q3 2016. 164 funds tracked by Wall St. Rank hold GWPH as of Q4 2016.

Dialectic Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2016 after selling out during the quarter.
Dialectic Capital Management sold 4,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2016, an estimated $531K.
Dialectic Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 2 quarters.
Dialectic Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $531K in Q3 2016.
164 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2016.

Based on Dialectic Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.